Clinical Trial Update: Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing bevacizumab as an adjunct to laser panretinal photocoagulation for proliferative diabetic retinopathy, with the study status li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Instituto do Coracao | Conditions: Proliferative Diabetic Retinopathy | Phase 2 | Status: UNKNOWN